发明公开
EP2586862A1 DETECTION METHOD FOR NOVEL ROS1 FUSION PRODUCT
有权
VERFAHREN ZUM NACHWEIS EINES NEUEN ROS1-FUSIONSPRODUKTS
- 专利标题: DETECTION METHOD FOR NOVEL ROS1 FUSION PRODUCT
- 专利标题(中): VERFAHREN ZUM NACHWEIS EINES NEUEN ROS1-FUSIONSPRODUKTS
-
申请号: EP11798177.9申请日: 2011-06-22
-
公开(公告)号: EP2586862A1公开(公告)日: 2013-05-01
- 发明人: TAKEUCHI Kengo , ISHIKAWA Yuichi , MANO Hiroyuki , SODA Manabu , SAI Eirin
- 申请人: Astellas Pharma Inc. , Japanese Foundation For Cancer Research , Educational Foundation Jichi Medical University
- 申请人地址: 3-11, Nihonbashi-Honcho 2-chome Chuo-ku Tokyo 103-8411 JP
- 专利权人: Astellas Pharma Inc.,Japanese Foundation For Cancer Research,Educational Foundation Jichi Medical University
- 当前专利权人: Astellas Pharma Inc.,Japanese Foundation For Cancer Research,Educational Foundation Jichi Medical University
- 当前专利权人地址: 3-11, Nihonbashi-Honcho 2-chome Chuo-ku Tokyo 103-8411 JP
- 代理机构: HOFFMANN EITLE
- 优先权: JP2010141728 20100622
- 国际公布: WO2011162295 20111229
- 主分类号: C12N15/09
- IPC分类号: C12N15/09 ; C12Q1/68 ; G01N33/68
摘要:
Polynucleotides which are novel causative genes for cancer are elucidated, and a detection method of the polynucleotides or polypeptides encoded by the polynucleotides, and a kit and a primer set for detection are provided, based on the knowledge gained by the elucidation. In the detection method, a fusion gene comprising part of an SDC4, CD74, EZR, SLC34A2, LRIG3, or TPM3 gene and part of a ROS1 gene, or a fusion protein encoded by the fusion gene is detected. The primer set or the detection kit comprises a sense primer designed based on a portion encoding SDC4, CD74, EZR, SLC34A2, LRIG3, or TPM3 and an antisense primer designed based on a portion encoding ROS1.
公开/授权文献
- EP2586862B9 DETECTION METHOD FOR NOVEL ROS1 FUSION PRODUCT 公开/授权日:2016-07-13
信息查询
IPC分类: